Clinical trial
A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas
NCT00314808 · Duke University, Other · Completed
Key facts
| NCT number | NCT00314808 |
|---|---|
| Title | A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas |
| Official title | A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas |
| Lead sponsor | Duke University, Other |
| Collaborators | Solvay Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain Neoplasms, Nausea, Vomiting |
| Intervention type | Drug |
| Interventions | Dronabinol |
| Enrollment | 33 |
| Start date | Apr 1, 2006 |
| Primary completion | Oct 1, 2011 |
| Completion | Apr 1, 2012 |
| First posted | Apr 17, 2006 |
| Last update posted | Jul 16, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: